Stock listing
A413XF Stock Price, News, Filings & Events — Seres Therapeutics, Inc.
Selected listing: A413XF · LS · EUR · DE
This page tracks Seres Therapeutics, Inc.'s A413XF:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A413XF:LS. A413XF:LS is the stock-level entry point for investors researching Seres Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A413XF:LS
- Asset type
- Stock
- Market cap
- $50.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Seres Therapeutics, Inc. A413XF:LS stock context
This page tracks Seres Therapeutics, Inc.'s A413XF:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A413XF:LS. A413XF:LS is the stock-level entry point for investors researching Seres Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Seres Therapeutics, Inc.
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 1, 2026
Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoin...
August 5, 2026
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC...
July 8, 2026
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cas...
June 5, 2026
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
May 12, 2026
Seres Therapeutics, Inc. earnings calls
Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call
March 13, 2025 · Replay with transcript and chapters
Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call
November 13, 2024 · Replay with transcript and chapters
Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call
August 13, 2024 · Replay with transcript and chapters
Research Seres Therapeutics, Inc.
Seres Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A413XF:LS.
Seres Therapeutics, Inc. company profile
View the public company page for Seres Therapeutics, Inc. on 6ix.
Seres Therapeutics, Inc. news
Read company news and market updates connected to Seres Therapeutics, Inc..
Seres Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Seres Therapeutics, Inc..
Alternate listings
MCRB:NASDAQ
US · USD
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
1S90:GETTEX
DE · EUR
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
A413XF:LSX
DE · EUR
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
MCRB:BOATS
US · USD
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
MCRB:BX
CH · CHF
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
1S90:FWB
DE · EUR
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
1S90:SWB
DE · EUR
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.
1S90:TRADEGATE
DE · EUR
Alternate listing for Seres Therapeutics, Inc.; the primary context on this page is A413XF:LS.